A previous study has demonstrated elevated levels of soluble CD163 in LN patients, with significant correlations with renal SLEDAI, and it could potentially behave as a histological biomarker that correlates with CD163 cells in the glomeruli [65]. The gene discussed is CD163; the disease is lobular neoplasia.